| Filed On | Filing |
|---|---|
| 10 Sep 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Received 4,000 shares by exercise or conversion ($17.2K) · Sold 8,000 shares ($173K) |
| 14 Aug 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Received 30,000 shares by exercise or conversion ($129K) · Sold 30,000 shares ($608K) |
| 07 Jul 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Received 4,000 shares by exercise or conversion ($17.2K) · Sold 8,000 shares ($143K) |
| 02 Jul 2026 |
Form 4: Sumer Jacquelyn L, Chief Legal Officer
Received 2,470 shares as a grant or award ($21.2K) |
| 02 Jul 2026 |
Form 4: Fenton Mary Kay, Chief Financial Officer
Received 1,541 shares as a grant or award ($13.3K) |
| 18 Jun 2026 |
Form 4: Rosenberg Anthony, Director
Granted 25,319 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Meek David D., Director
Granted 25,319 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Webster Stephen W, Director
Granted 25,319 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Allen Andrew R, Director
Granted 21,781 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Thistle Mary, Director
Granted 25,319 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Doyle Mittie, Director
Granted 21,781 Stock Option (Right to Buy) |
| 06 May 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Received 4,000 shares by exercise or conversion ($17.2K) · Sold 8,000 shares ($117K) |
| 09 Mar 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Received 4,000 shares by exercise or conversion ($17.2K) · Sold 8,000 shares ($125K) |
| 26 Feb 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Sold 1,780 shares ($25.2K) |
| 25 Feb 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Sold 1,752 shares ($24.5K) · Sold 3,601 shares ($52.1K) |
| 25 Feb 2026 |
Form 4: Ahmed Nadim, Director
Sold 13,515 shares ($196K) |
| 25 Feb 2026 |
Form 4: Jones Jeffrey Alan, Chief Medical Officer
Sold 4,582 shares ($66.3K) |
| 25 Feb 2026 |
Form 4: Sumer Jacquelyn L, Chief Legal Officer
Sold 3,601 shares ($52.1K) |
| 23 Feb 2026 |
Form 4: Jones Jeffrey Alan, Chief Medical Officer
Sold 4,982 shares ($67.9K) |
| 23 Feb 2026 |
Form 4: Michaelson Jennifer, Chief Scientific Officer
Sold 11,742 shares ($165K) · Received 8,000 shares by exercise or conversion ($34.4K) |
Loading...